Navigation Links
Onyx Pharmaceuticals Reports Third Quarter 2009 Financial Results; Nexavar Global Net Sales Top $229 Million, 27% Increase Over Third Quarter 2008
Date:11/3/2009

cial measures that management uses are not prepared in accordance with, and should not be considered in isolation of, or an as alternative to, measurements required by GAAP.

These non-GAAP financial measures exclude the following items from GAAP net income and diluted EPS:

Employee stock-based compensation: Onyx management excludes the effects of employee stock-based compensation because of varying available valuation methodologies, subjective assumptions and the variety of award types; such exclusion facilitates comparisons of Onyx's operating results to peer companies.

Imputed interest related to the application of ASC Subtopic 470-20: Onyx management excludes the effects of imputed interest related to the Company's convertible senior notes due 2016 because this expense is non-cash; such exclusion facilitates comparisons of Onyx's cash operating results to peer companies.

Milestone payments and acquisition related transaction costs: Onyx management excludes the effects of milestone payments and acquisition related transaction costs as they do not relate to the normal and recurring transactions of our business; such exclusions allow for a better representation of the ongoing economics of the business, facilitates comparison to peer companies and is reflective of how Onyx management internally manages the business.

    (6) Under the "if-converted" method, potential common shares related to
    the Company's convertible senior notes were included in non-GAAP net
    income per share - diluted for the three and nine months ended September
    30, 2009 because their effect is dilutive.



                         ONYX PHARMACEUTICALS, INC.
                          CONDENSED BALANCE SHEETS
                                                       (In thousands)
                                                 Sep. 30,           Dec. 31,
                                        
'/>"/>
SOURCE  Onyx Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 

Related medicine news :

1. Cumberland Pharmaceuticals to Present at Lazard Healthcare Conference in New York on November 17, 2009
2. Vanda Pharmaceuticals Reports Third Quarter 2009 Results
3. Amylin Pharmaceuticals and Takeda Enter into Worldwide Agreement to Co-Develop and Commercialize Compounds for Obesity
4. VIA Pharmaceuticals Featured at Cambridge Healthtech Institute Discovery on Target 2009 Conference
5. Vanda Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 2, 2009
6. Amira Pharmaceuticals to Present at the BIO Investor Forum in San Francisco
7. Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Glycemic Parameters and was not Associated with Depression or Suicidal Ideation
8. DUSA Pharmaceuticals Named to Deloittes 2009 Technology Fast 500 List of Fastest Growing Companies in North America
9. Peregrine Pharmaceuticals Announces Implementation of 1:5 Reverse Stock Split to Take Effect October 19, 2009
10. Proteolix, Inc. to be Acquired By Onyx Pharmaceuticals
11. Amira Pharmaceuticals to Present at Montgomery Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Dec. 15 Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged ... today announced that shareholders had approved all three resolutions that the Company had proposed at ... follows: , , Description of ... Votes ... For ...
(Date:12/15/2009)... SUNNYVALE, Calif., Dec. 15 Palo Alto ... Shinshu University has deployed its PA-4000 Series next-generation ... network and for enhanced visibility and control over ... University is a Japanese national university with eight ... in 1949 by integrating a number of academic ...
(Date:12/15/2009)... Proceeds will be donated to the Lupus Foundation of ... ,, WASHINGTON, Dec. 15 Julian Lennon, son ... today released their new digital single, "LUCY," to raise ... until March 15, 2010, 100 percent of the proceeds ... the Lupus Foundation of America (LFA), and the Saint ...
(Date:12/15/2009)... Dec. 15 Vitech Systems Group, a ... Management (CRM) software, announced today that it has ... for the Screen Actors Guild-Producers Pension & Health ... customer service capabilities to SAG-PH call center personnel ... was installed using Vitech,s V3 Benefits Administration System ...
(Date:12/15/2009)... levels of leptin associated with lower dementia risk, research ... blood levels of leptin, a hormone that regulates appetite, ... "Hopefully, in 10 or 15 years this may be ... the risk of Alzheimer,s disease," said senior study author ... Boston University School of Medicine. "Or it may be ...
Breaking Medicine News(10 mins):Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 2Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 3Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 2Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 3Health News:Julian Lennon and James Scott Cook Release New Charity Single 'LUCY' to Raise Awareness and Funds for Lupus Research 2Health News:Screen Actors Guild - Producers Pension & Health Plans Live on New CRM Solution 2Health News:Fat Hormone May Protect Against Alzheimer's 2Health News:Fat Hormone May Protect Against Alzheimer's 3
... therapy should be , , FRIDAY, May 15 (HealthDay ... to better customize the treatment of prostate cancer. , ... men could survive with metastatic prostate cancer have been ... who say such information would help doctors individualize treatments. ...
... CDC says confirmed cases, including 2 new deaths, may not ... 16 (HealthDay News) -- While the official tally of confirmed ... the Centers for Disease Control and Prevention now estimate the ... Also on Friday, health officials announced two new deaths linked ...
... Find the Solutions to their Infertility Issues by Bridging the Gap ... ... (PRWEB) May 16, 2009 -- National Fertility Link ... be pregnant. National Fertility Link helps Infertile couples find the best ...
... emergency department is overcrowded with seriously sick and injured ... other emergency departments. But the benefits of "diversion" are ... crowded, and the greater distance to that other hospital ... 2006, a group of teaching hospitals in Boston agreed ...
... of these developments, The Villa Group encourages travelers to ... Mexico now. CDC today removed the Travel Health ... for travel health safety. SAN DIEGO, May 15 ... H1N1 virus in Mexico, CDC has noted that the ...
... resume visits to Mexican ports of call based on ... which is no longer recommending against non-essential travel to ... completed, those vessels will revert to their original routes ... through mid-June with the exception of the Holiday which ...
Other Medicine News:Health News:An Aid to Tailoring Prostate Cancer Treatment 2Health News:Swine Flu May Have Infected More Than 100,000 Americans 2Health News:Swine Flu May Have Infected More Than 100,000 Americans 3Health News:Swine Flu May Have Infected More Than 100,000 Americans 4Health News:Swine Flu May Have Infected More Than 100,000 Americans 5Health News:Swine Flu May Have Infected More Than 100,000 Americans 6Health News:Swine Flu May Have Infected More Than 100,000 Americans 7Health News:Swine Flu May Have Infected More Than 100,000 Americans 8Health News:Swine Flu May Have Infected More Than 100,000 Americans 9Health News:Swine Flu May Have Infected More Than 100,000 Americans 10Health News:Swine Flu May Have Infected More Than 100,000 Americans 11Health News:Swine Flu May Have Infected More Than 100,000 Americans 12Health News:Fewer Than One Percent of Infertile Couples Who Need Treatment Receive It - Website to Bridge Gap Between Infertile Couples and Fertility Clinics 2Health News:Fewer Than One Percent of Infertile Couples Who Need Treatment Receive It - Website to Bridge Gap Between Infertile Couples and Fertility Clinics 3Health News:Centers for Disease Control Lifts Travel Health Warning for Mexico 2Health News:Carnival Cruise Lines to Resume Port Calls in Mexico 2
(Date:12/15/2009)... Dec. 15 Certified healthcare providers who ... complications from the H1N1 flu virus may now ... the Department of Health announced today. ,, ... everyone because approximately 3.2 million doses of vaccine ... it to individuals in the priority groups. ,, ...
(Date:12/15/2009)... ,, Reportlinker.com announces that a new market ... ,, Hepatitis B Vaccines - Pipeline ... ,, http://www.reportlinker.com/p0167309/Hepatitis-B-Vaccines---Pipeline-Analysis-and-Market-Forecasts-to-2015.html ,, Hepatitis B ... to 2015 ,, Summary ,, ... "Hepatitis B Vaccines - Pipeline Analysis and ...
(Date:12/15/2009)... Israel, December 15 EnzySurge Ltd.,(EnzySurge), ... advanced chronic,wound management market, announced today that ... and Drug Administration (FDA) to market its ... also cleared,DermaSept, an Over-the-Counter version of the ... EnzySurge is the developer of the DermaStream(R) ...
Breaking Medicine Technology:Department of Health Urges Expanded H1N1 Vaccination Efforts to Include All Patients 2Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 2Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 3Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 4Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 5Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 6Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 7EnzySurge Receives FDA Approval for SilverStream(TM) Innovative Wound Management Solution 2Mindray Medical to Present at the Morgan Stanley Global Healthcare Unplugged Conference 54839 1Mindray Medical to Present at the Morgan Stanley Global Healthcare Unplugged Conference 54839 2Are You Connected 3F AIM and GASICORP Expand Global Reach Through Landmark Strategic Alliance 54836 1Are You Connected 3F AIM and GASICORP Expand Global Reach Through Landmark Strategic Alliance 54836 2Are You Connected 3F AIM and GASICORP Expand Global Reach Through Landmark Strategic Alliance 54836 3Phytomedics Inc Announces Publication of the Phase 2b Clinical Trial Results of an Extract of the Chinese Herbal Remedy Tripterygium wilfordii Hook F 4868 1Phytomedics Inc Announces Publication of the Phase 2b Clinical Trial Results of an Extract of the Chinese Herbal Remedy Tripterygium wilfordii Hook F 4868 2Phytomedics Inc Announces Publication of the Phase 2b Clinical Trial Results of an Extract of the Chinese Herbal Remedy Tripterygium wilfordii Hook F 4868 3
... April 27 Calvin A. Grant, MD,Retina ... 60-patient,retrospective case control study that was designed ... 0.09mg ophthalmic solution) in Lucentis(R),(ranibizumab) treatment of ... in an oral poster presentation at,the 2008 ...
... Schering-Plough Corporation,(NYSE: SGP ) today reported that ... Phase II study of boceprevir, its investigational oral ... chronic,hepatitis C virus (HCV) genotype 1 were presented ... for the Study of the Liver (EASL). The,ongoing ...
Other Medicine Technology:Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) 2Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) 3Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) 4Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 2Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 3Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 4Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 5Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 6Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 7Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 8Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 9
... stethoscope earmolds add comfort and enhance hearing ... ambulance paramedics, Flight-for-Life helicopter personnel, emergency technicians ... are specific in design and can be ... used in today's industry to ensure clear ...
Advanced architecture. Small, lightweight and compact. Easy to use....
... benefits of fibre bronchoscopy: The HF-compatible V ... all other fibre bronchoscopes are measured., ... PENTAX, including the FB-19TV, FB-18V and FB-15V ... and the pediatric FB-8V, offer much better ...
... Fujinon's therapeutic fiberoptic ... 2.6mm operating channel with ... The large channel allows ... easier passage of cytology ...
Medicine Products: